BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25812207)

  • 1. Development and evaluation of a live attenuated camelpox vaccine from a local field isolate of the virus.
    Abdellatif MM; Ibrahim AA; Khalafalla AI
    Rev Sci Tech; 2014 Dec; 33(3):831-8. PubMed ID: 25812207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More cell culture passaged Camelpox virus sequences found resembling those of vaccinia virus.
    Khalafalla AI; Al Hosani MA; Ishag HZA; Al Muhairi SS
    Open Vet J; 2020 Aug; 10(2):144-156. PubMed ID: 32821659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a live cell culture camelpox vaccine.
    Hafez SM; al-Sukayran A; dela Cruz D; Mazloum KS; al-Bokmy AM; al-Mukayel A; Amjad AM
    Vaccine; 1992; 10(8):533-9. PubMed ID: 1621417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camelpox virus.
    Duraffour S; Meyer H; Andrei G; Snoeck R
    Antiviral Res; 2011 Nov; 92(2):167-86. PubMed ID: 21945248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Another case of mistaken identity? Vaccinia virus in another live Camelpox vaccine.
    Saud Z; Butt TM
    Biologicals; 2020 May; 65():39-41. PubMed ID: 32334926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camelpox: epidemiology, diagnosis and control measures.
    Bhanuprakash V; Prabhu M; Venkatesan G; Balamurugan V; Hosamani M; Pathak KM; Singh RK
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1187-201. PubMed ID: 20954883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camelpox: A brief review on its epidemiology, current status and challenges.
    Dahiya SS; Kumar S; Mehta SC; Narnaware SD; Singh R; Tuteja FC
    Acta Trop; 2016 Jun; 158():32-38. PubMed ID: 26902797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camelpox: target for eradication?
    Bray M; Babiuk S
    Antiviral Res; 2011 Nov; 92(2):164-6. PubMed ID: 21945042
    [No Abstract]   [Full Text] [Related]  

  • 9. Zoonotic cases of camelpox infection in India.
    Bera BC; Shanmugasundaram K; Barua S; Venkatesan G; Virmani N; Riyesh T; Gulati BR; Bhanuprakash V; Vaid RK; Kakker NK; Malik P; Bansal M; Gadvi S; Singh RV; Yadav V; Sardarilal ; Nagarajan G; Balamurugan V; Hosamani M; Pathak KM; Singh RK
    Vet Microbiol; 2011 Aug; 152(1-2):29-38. PubMed ID: 21571451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real time PCR: a rapid tool for potency estimation of live attenuated camelpox and buffalopox vaccines.
    Prabhu M; Siva Sankar MS; Bhanuprakash V; Venkatesan G; Bora DP; Yogisharadhya R; Balamurugan V
    Biologicals; 2012 Jan; 40(1):92-5. PubMed ID: 22019252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of Camelpox virus isolates from Bikaner, India: Evidence of its endemicity.
    Dahiya SS; Kumar S; Mehta SC; Singh R; Nath K; Narnaware SD; Tuteja FC
    Acta Trop; 2017 Jul; 171():1-5. PubMed ID: 28315306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation and genetic characteristics of a Moroccan strain of Camel pox virus.
    Bamouh Z; Hamdi J; Elkarhat Z; Fellahi S; Omari Tadlaoui K; Watts DM; Fassi Fihri O; Elharrak M
    Vaccine; 2022 Oct; 40(45):6471-6480. PubMed ID: 36192275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery and molecular characterization of live Camelpox virus from skin 12 months after onset of clinical signs reveals possible mechanism of virus persistence in herds.
    Yousif AA; Al-Naeem AA
    Vet Microbiol; 2012 Oct; 159(3-4):320-6. PubMed ID: 22595140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an Inactivated Camelpox Vaccine from Attenuated Camelpox Virus Strain: Safety and Protection in Camels.
    Zhugunissov K; Mambetaliyev M; Sarsenkulova N; Tabys S; Kenzhebaeva M; Issimov A; Abduraimov Y
    Animals (Basel); 2023 Apr; 13(9):. PubMed ID: 37174551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of mistaken identity? Vaccinia virus in a live camelpox vaccine.
    Yousif AA; Al-Ali AM
    Biologicals; 2012 Nov; 40(6):495-8. PubMed ID: 23068316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of live replicating sheeppox vaccine strains in Ovines.
    Yogisharadhya R; Bhanuprakash V; Hosamani M; Venkatesan G; Balamurugan V; Bora DP; Bhanot V; Prabhu M; Singh RK
    Biologicals; 2011 Nov; 39(6):417-23. PubMed ID: 21993305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Vero cell-attenuated Goatpox virus provides protection against virulent virus challenge.
    Hosamani M; Nandi S; Mondal B; Singh RK; Rasool TJ; Bandyopadhyay SK
    Acta Virol; 2004; 48(1):15-21. PubMed ID: 15230470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Diagnosed Case of Camelpox Virus in Israel.
    Erster O; Melamed S; Paran N; Weiss S; Khinich Y; Gelman B; Solomony A; Laskar-Levy O
    Viruses; 2018 Feb; 10(2):. PubMed ID: 29438294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Evaluation of a Live Attenuated Egg-Based Camelpox Vaccine.
    Zhugunissov K; Kilibayev S; Mambetaliyev M; Zakarya K; Kassenov M; Abduraimov Y; Bulatov Y; Azanbekova M; Absatova Z; Abeuov K; Nurgaziev R; Renukaradhya GJ; Tabynov K
    Front Vet Sci; 2021; 8():721023. PubMed ID: 34485443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A live attenuated virus vaccine against sheep pox.
    Sólyom F; Perenlei L; Roith J
    Acta Vet Acad Sci Hung; 1981; 28(4):389-98. PubMed ID: 6269410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.